(Q42486260)

1 November 2017

title

Corticosteroid feedback resistance in rats genetically selected for increased dopamine responsiveness (English)

1 reference

1 November 2017

Rots NY

1

1 reference

1 November 2017

Cools AR

series ordinal

2

1 reference

1 November 2017

de Jong J

series ordinal

3

1 reference

1 November 2017

De Kloet ER

series ordinal

4

1 reference

1 November 2017

publication date

1 February 1995

1 reference

Journal of Neuroendocrinology

1 November 2017

published in

1 reference

1 November 2017

volume

7

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

153-161

1 reference

Basal and stress-induced corticosterone secretion is decreased by lesion of mesencephalic dopaminergic neurons

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Stress-induced sensitization to amphetamine and morphine psychomotor effects depend on stress-induced corticosterone secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

GBR12909 stimulates hypothalamo-pituitary-adrenal activity by inhibition of uptake at hypothalamic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Critical role of the hypothalamic pituitary adrenal axis in amphetamine-induced sensitization of behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Adrenocortical hormone status affects responses to dopamine receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Effects of adrenalectomy on responses mediated by dopamine D-1 and D-2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Corticosterone levels determine individual vulnerability to amphetamine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Comparison between the behavioural effects of septal and hippocampal lesions: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Corticotropin-releasing factor (CRF)-like immunoreactivity in the adrenal medulla

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Physiological role of corticotropin-releasing factor in the control of adrenocorticotropin-mediated corticosterone release from the rat adrenal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Life events-induced decrease of corticosteroid type I receptors is associated with reduced corticosterone feedback and enhanced vulnerability to amphetamine self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Hippocampal type I and type II corticosteroid receptor affinities are reduced in rats predisposed to develop amphetamine self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

Chronic stimulation of the pituitary-adrenal axis in rats by interleukin-1 beta infusion: in vivo and in vitro studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2826.1995.TB00678.X

10.1111/J.1365-2826.1995.TB00678.X

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference